
### [MONDO:0015333](http://purl.obolibrary.org/obo/MONDO_0015333)
**Label:** progeroid syndrome

**Subclasses:** [MONDO:0008926](http://purl.obolibrary.org/obo/MONDO_0008926) (COFS syndrome), [MONDO:0016006](http://purl.obolibrary.org/obo/MONDO_0016006) (Cockayne syndrome), [MONDO:0016584](http://purl.obolibrary.org/obo/MONDO_0016584) (mandibuloacral dysplasia), [MONDO:0019600](http://purl.obolibrary.org/obo/MONDO_0019600) (xeroderma pigmentosum), [MONDO:0016354](http://purl.obolibrary.org/obo/MONDO_0016354) (xeroderma pigmentosum-Cockayne syndrome complex), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0010002](http://purl.obolibrary.org/obo/MONDO_0010002) (Rothmund-Thomson syndrome), 

**Corr. equiv. classes:** [Orphanet:1466](http://www.orpha.net/ORDO/Orphanet_1466), [Orphanet:220295](http://www.orpha.net/ORDO/Orphanet_220295), [Orphanet:191](http://www.orpha.net/ORDO/Orphanet_191), [OMIM:212540](http://purl.obolibrary.org/obo/OMIM_212540), [Orphanet:910](http://www.orpha.net/ORDO/Orphanet_910), [Orphanet:528](http://www.orpha.net/ORDO/Orphanet_528), [Orphanet:2909](http://www.orpha.net/ORDO/Orphanet_2909), [OMIM:268400](http://purl.obolibrary.org/obo/OMIM_268400), [Orphanet:2457](http://www.orpha.net/ORDO/Orphanet_2457), 

**Class expressions from DL-Learner:**

- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0004334](http://purl.obolibrary.org/obo/HP_0004334) (Dermal atrophy) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0004322](http://purl.obolibrary.org/obo/HP_0004322) (Short stature) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0001510](http://purl.obolibrary.org/obo/HP_0001510) (Growth delay) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) 72.22%
- [HP:0000002](http://purl.obolibrary.org/obo/HP_0000002) (Abnormality of body height) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 72.22%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 72.22%


